These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28809001)

  • 1. Reverse Phase Protein Arrays and Drug Discovery.
    Macleod KG; Serrels B; Carragher NO
    Methods Mol Biol; 2017; 1647():153-169. PubMed ID: 28809001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
    Lu Y; Ling S; Hegde AM; Byers LA; Coombes K; Mills GB; Akbani R
    Semin Oncol; 2016 Aug; 43(4):476-83. PubMed ID: 27663479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
    Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
    Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Biomarker Proteins Using Reverse-Phase Protein Arrays.
    Yamada T
    Proteomics Clin Appl; 2020 Jul; 14(4):e1900120. PubMed ID: 32109350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.
    Akbani R; Becker KF; Carragher N; Goldstein T; de Koning L; Korf U; Liotta L; Mills GB; Nishizuka SS; Pawlak M; Petricoin EF; Pollard HB; Serrels B; Zhu J
    Mol Cell Proteomics; 2014 Jul; 13(7):1625-43. PubMed ID: 24777629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse phase protein arrays in signaling pathways: a data integration perspective.
    Creighton CJ; Huang S
    Drug Des Devel Ther; 2015; 9():3519-27. PubMed ID: 26185419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse Phase Protein Arrays elucidate mechanisms-of-action and phenotypic response in 2D and 3D models.
    Pawlak M; Carragher NO
    Drug Discov Today Technol; 2017 Mar; 23():7-16. PubMed ID: 28647089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse Phase Protein Arrays.
    Davis JB; Andes S; Espina V
    Methods Mol Biol; 2021; 2237():103-122. PubMed ID: 33237412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid Pin Protein Array Printing Platforms.
    Espina V; Mueller C
    Adv Exp Med Biol; 2019; 1188():61-75. PubMed ID: 31820383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility and Crossplatform Validation of Reverse-Phase Protein Array Data.
    Byron A
    Adv Exp Med Biol; 2019; 1188():181-201. PubMed ID: 31820389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Arrays III: Reverse-Phase Protein Arrays.
    Yuan Y; Hong X; Lin ZT; Wang H; Heon M; Wu T
    Methods Mol Biol; 2017; 1654():279-289. PubMed ID: 28986799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Screening Platforms and RPPA.
    Dawson JC; Warchal SJ; Carragher NO
    Adv Exp Med Biol; 2019; 1188():203-226. PubMed ID: 31820390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies.
    Byron A; Bernhardt S; Ouine B; Cartier A; Macleod KG; Carragher NO; Sibut V; Korf U; Serrels B; de Koning L
    Sci Rep; 2020 Dec; 10(1):21985. PubMed ID: 33319783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and use of reverse protein microarrays.
    Pin E; Federici G; Petricoin EF
    Curr Protoc Protein Sci; 2014 Feb; 75():27.7.1-27.7.29. PubMed ID: 24510676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling Glycoproteins on Functionalized Reverse Phase Protein Array.
    Zhang Y; Zhang L; Iliuk A; Tao WA
    Methods Mol Biol; 2021; 2237():207-215. PubMed ID: 33237420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Biomarker Proteins Using Reverse Capture Protein Microarrays.
    Jozwik C; Eidelman O; Starr J; Pollard HB; Srivastava M
    Methods Mol Biol; 2017; 1513():209-222. PubMed ID: 27807840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
    Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
    Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Raw RPPA Data and Their Conversion to Analysis-Ready Data.
    Akbani R; Ling S; Lu Y
    Adv Exp Med Biol; 2019; 1188():165-180. PubMed ID: 31820388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration.
    Coarfa C; Grimm SL; Rajapakshe K; Perera D; Lu HY; Wang X; Christensen KR; Mo Q; Edwards DP; Huang S
    J Biomol Tech; 2021 Apr; 32(1):15-29. PubMed ID: 34025221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse phase protein microarrays and their utility in drug development.
    Sereni MI; Pierobon M; Angioli R; Petricoin EF; Frederick MJ
    Methods Mol Biol; 2013; 986():187-214. PubMed ID: 23436414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.